Results 1 to 10 of about 115,653 (351)

Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization

open access: yesFrontiers in Microbiology, 2023
Adeno-associated viruses (AAV) are among the foremost vectors for in vivo gene therapy. A number of monoclonal antibodies against several serotypes of AAV have previously been prepared.
Edward E. Large, Michael S. Chapman
doaj   +3 more sources

Muscle regeneration affects Adeno Associated Virus 1 mediated transgene transcription [PDF]

open access: goldScientific Reports, 2022
Duchenne muscular dystrophy is a severe neuromuscular disease causing a progressive muscle wasting due to mutations in the DMD gene that lead to the absence of dystrophin protein.
Amédée Mollard   +11 more
doaj   +2 more sources

An adeno-associated virus gene therapy strategy for anti-obesity treatment by nanocarrier-based delivery systems [PDF]

open access: yesJournal of Nanobiotechnology
Gut microbiota is increasingly recognized for its profound influence on host metabolism. However, the mechanisms underlying the distinct metabolic phenotype observed in germ-free (GF) mice are not fully understood.
Li Li   +11 more
doaj   +2 more sources

Sclerosing Sialadenitis Is Associated With Salivary Gland Hypofunction and a Unique Gene Expression Profile in Sjögren’s Syndrome

open access: yesFrontiers in Immunology, 2021
PurposeTo develop a novel method to quantify the amount of fibrosis in the salivary gland and to investigate the relationship between fibrosis and specific symptoms associated with Sjögren’s syndrome (SS) using this method.Materials and MethodsParaffin ...
Hongen Yin   +6 more
doaj   +1 more source

Advancing Luciferase-Based Antibody Immunoassays to Next-Generation Mix and Read Testing

open access: yesBiosensors, 2023
Antibody measurements play a central role in the diagnosis of many autoimmune and infectious diseases. One antibody detection technology, Luciferase Immunoprecipitation Systems (LIPS), utilizes genetically encoded recombinant luciferase antigen fusion ...
Peter D. Burbelo   +2 more
doaj   +1 more source

Correction of LAMP3-associated salivary gland hypofunction by aquaporin gene therapy

open access: yesScientific Reports, 2022
Sjögren’s disease (SjD) is a chronic autoimmune sialadenitis resulting in salivary gland hypofunction with dry mouth symptom. Previous studies showed that lysosome-associated membrane protein 3 (LAMP3) overexpression is involved in the development of ...
Hiroyuki Nakamura   +7 more
doaj   +1 more source

Sarcopenia and coexistent risk factors detected using the ‘Yubi-wakka’ (finger-ring) test in adults aged over 65 years in the public annual health check-up in Tama City, Tokyo: a cross-sectional study

open access: yesBMJ Open, 2022
Objectives To examine the positive rate of sarcopenia using the ‘Yubi-wakka’ (finger-ring) test and associated risk factors among adults aged 65 years and older.Design Cross-sectional study.Setting We used the Yubi-wakka test, which has been developed ...
Hiroyuki Nakamura   +5 more
doaj   +1 more source

LAMP3 transfer via extracellular particles induces apoptosis in Sjögren’s disease

open access: yesScientific Reports, 2023
Sjögren’s disease (SjD) is an autoimmune disease that affects exocrine tissues and is characterized by increased apoptosis in salivary and lacrimal glands.
Tsutomu Tanaka   +7 more
doaj   +1 more source

Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors

open access: yesMolecular Therapy: Methods & Clinical Development, 2022
Gene therapy using neurotropic adeno-associated virus vectors represents an emerging solution for genetic disorders affecting the central nervous system. The first approved central nervous system-targeting adeno-associated virus gene therapy, Zolgensma®,
Makoto Horiuchi   +10 more
doaj   +1 more source

Adeno‐associated virus (AAV)-based gene therapy for glioblastoma

open access: yesCancer Cell International, 2021
Glioblastoma (GBM) is the most common and malignant Grade IV primary craniocerebral tumor caused by glial cell carcinogenesis with an extremely poor median survival of 12–18 months.
Xin Xu   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy